rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Aurobindo Pharma Ltd.

524804 AUROPHARMA Group (A)

11 Mar,15:29
1093.60
0.75 (0.07%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Aurobindo Pharma Ltd.

BUYSELL

37,052 1,092.85 1,098.50 - 1,081.05 1,592.55 - 985.00 63,516.29

News for Aurobindo Pharma Ltd.

Aurobindo...
Aurobindo Terminates Pentavalent Vaccine Pact with Hilleman Labs
Aurobindo Pharma's subsidiary Auro Vaccines has terminated a license agreement with Singapore-based Hilleman Laboratories for a pentavalent vaccine candidate. The agreement, signed in September...
Mar 05, 2025 15:26
Pharma Stocks...
Pharma Stocks Decline Amid Tariff Threats - PTI
Pharmaceutical stocks closed lower on Wednesday due to US President Trump's announcement of potential tariffs on auto, semiconductor, and pharmaceutical imports. Dr Reddy's, Zydus Lifesciences,...
Feb 19, 2025 19:23
Aurobindo Pharma...
Aurobindo Pharma Starts Europe Supplies from China Plant in April
Aurobindo Pharma will begin supplying drugs to Europe from its new China facility starting in April. The company expects significant revenue growth from the plant over the next few years.
Feb 16, 2025 10:58
JIS Group Invests...
JIS Group Invests Rs 450cr to Expand Education in Bengal
JIS Group announces Rs 450 crore investment to expand its academic infrastructure in West Bengal, including a new university in Hooghly district. The group cites a conducive business environment...
Feb 07, 2025 21:40
Aurobindo Pharma Q3 Profit Dips 10% to Rs 846 cr
Aurobindo Pharma's net profit fell 10% to Rs 846 crore in Q3 FY25, while revenue rose to Rs 7,979 crore. The company attributes this to volume growth and new launches.
Feb 06, 2025 21:58

More News for Aurobindo Pharma Ltd. »

(Rs. Crore)

Financial Results of Aurobindo Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,645.6412,792.2811,287.1415,823.6813,266.48
Operating profit2,224.041,730.921,473.404,119.822,685.75
Interest182.60114.9816.9428.6895.58
Gross profit2,657.502,049.702,127.454,681.002,848.18
EPS (Rs)33.3521.0024.8353.1331.96

See more in Research Center »

News for Pharmaceuticals and health care

Bihar Exit...
Bihar Exit Policy: Cheques Distributed to 28 Beneficiaries
Bihar's Exit Policy 2023 facilitates land reclamation from non-functional units. 28 beneficiaries received cheques for returning plots, which will be allocated to new investors. The policy aims to...
Mar 11, 2025 23:06
UK EV Delegation...
UK EV Delegation Explores Kolkata Opportunities, FIDC Highlights Challenges
A UK delegation visited Kolkata to explore EV opportunities in India, while the FIDC highlighted financing challenges and proposed solutions to unlock USD 50 billion in EV financing by 2030.
Mar 11, 2025 22:49
GLAS Trust Moves...
GLAS Trust Moves NCLAT for Stay on Byju's AoA Amendments
GLAS Trust, a US-based lender to Byju's, has filed a petition in the NCLAT seeking a stay on amendments to the AoA of Aakash Educational Services, arguing they impact the CIRP process. The NCLAT...
Mar 11, 2025 22:30
DPIIT Reviews...
DPIIT Reviews Infra Project Challenges in AP, TN - PTI
The DPIIT's Project Monitoring Group reviewed critical challenges impacting mega infrastructure projects in Andhra Pradesh and Tamil Nadu, including Reliance Jio's 5G expansion.
Mar 11, 2025 22:27
Bharti Airtel...
Bharti Airtel Transfers Stake in Payments Bank to Airtel Ltd
Bharti Airtel has transferred its 69.94% stake in Airtel Payments Bank to its subsidiary Airtel Limited, an internal reorganisation with no impact on ownership. The transaction follows regulatory...
Mar 11, 2025 22:21

More News »

Top News

Bihar Exit...
Bihar Exit Policy: Cheques Distributed to 28 Beneficiaries
Bihar's Exit Policy 2023 facilitates land reclamation from non-functional units. 28 beneficiaries received cheques for returning plots, which will be allocated to new investors. The policy aims to...
Mar 11, 2025 23:06
PB Fintech to Invest Rs 696 Cr in PB Healthcare Services
PB Fintech, parent of Policybazaar, will invest Rs 696 crore in its subsidiary PB Healthcare Services in FY26 to grow its business. The investment will be made through share subscription or...
Mar 11, 2025 22:59
UK EV Delegation...
UK EV Delegation Explores Kolkata Opportunities, FIDC Highlights Challenges
A UK delegation visited Kolkata to explore EV opportunities in India, while the FIDC highlighted financing challenges and proposed solutions to unlock USD 50 billion in EV financing by 2030.
Mar 11, 2025 22:49
TCS Acquires Darshita Southern India Happy Homes for Rs 2,250 Crore
TCS has announced the acquisition of Darshita Southern India Happy Homes Pvt Ltd for Rs 2,250 crore. The deal involves the acquisition of land and building to serve as a delivery centre for TCS.
Mar 11, 2025 22:31
GLAS Trust Moves...
GLAS Trust Moves NCLAT for Stay on Byju's AoA Amendments
GLAS Trust, a US-based lender to Byju's, has filed a petition in the NCLAT seeking a stay on amendments to the AoA of Aakash Educational Services, arguing they impact the CIRP process. The NCLAT...
Mar 11, 2025 22:30

More Top News »

Report Card

PE Ratios
32.79
EPS (Rs.)
33.35
Sales (Rs. Cr)
2,916.63
Face Value (Rs.)
1
Net Profit Margin (%)
18.35
Last Bonus
1:1
Last Dividend(%)
150
Return on Average Equity
9.9

Compare 'Aurobindo Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,611.15
  • Compare
  • Divi's Laboratories Ltd.
  • 5,511.70
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,120.15
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,070.70
  • Compare
  • Zydus Lifesciences Ltd.
  • 893.20
  • Compare
  • Max Healthcare Institute Ltd.
  • 964.05
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,149.75
  • Compare

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,     ago

You would have  Rs. 1,001.19 

Add to Portfolio
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close